Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients | Zendy

Ajit P. Limaye | Zendy; Katharine A. Kirby | Zendy; Gordon D. Rubenfeld | Zendy; Wendy M. Leisenring | Zendy; Eileen M. Bulger | Zendy; Margaret J. Neff | Zendy; Nicole S. Gibran | Zendy; Meei Li Huang | Zendy; Tracy K. Santo Hayes | Zendy; Lawrence Corey | Zendy; Michael Boeckh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients

Author(s) -

Ajit P. Limaye,

Katharine A. Kirby,

Gordon D. Rubenfeld,

Wendy M. Leisenring,

Eileen M. Bulger,

Margaret J. Neff,

Nicole S. Gibran,

Meei Li Huang,

Tracy K. Santo Hayes,

Lawrence Corey,

Michael Boeckh

Publication year - 2008

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.300.4.413

Subject(s) - medicine , odds ratio , intensive care unit , confidence interval , incidence (geometry) , cytomegalovirus , viremia , immunosuppression , logistic regression , interquartile range , betaherpesvirinae , immunology , viral disease , herpesviridae , virus , physics , optics

Cytomegalovirus (CMV) infection is associated with adverse clinical outcomes in immunosuppressed persons, but the incidence and association of CMV reactivation with adverse outcomes in critically ill persons lacking evidence of immunosuppression have not been well defined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research